1 Min Read
Nov 30 (Reuters) - Promis Neurosciences Inc -
* Promis Neurosciences announces five novel alzheimer’s disease therapeutic candidates block spreading of toxic prion-like forms of amyloid beta Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.